Home - Products - Others - Other Targets - Kinase Domain of Insulin Receptor (3)

Kinase Domain of Insulin Receptor (3)

CAS No. ———

Kinase Domain of Insulin Receptor (3)( ——— )

Catalog No. M41562 CAS No. ———

Kinase Domain of Insulin Receptor (3)

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Kinase Domain of Insulin Receptor (3)
  • Note
    Research use only, not for human use.
  • Brief Description
    Kinase Domain of Insulin Receptor (3)
  • Description
    Kinase Domain of Insulin Receptor (3)
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    ———
  • Formula Weight
    1702.77
  • Molecular Formula
    C72H108N19O27
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • [D-Pro4,D-Trp7,9,10,...

    [D-Pro4,D-Trp7,9,10,Val8]-Substance P (4-11)

  • Protein Kinase C (19...

    Protein Kinase C (19-31) TFA, a peptide inhibitor of protein kinase C (PKC), derived from the pseudo-substrate regulatory domain of PKCa (residues 19-31) with a serine at position 25 replacing the wild-type alanine, is used as protein kinase C substrate peptide for testing the protein kinase C activity.

  • (Ser4,Ile8)-Oxytocin

    Isotocin ((Ser4,Ile8)-Oxytocin) is a polypeptide that can be found by peptide screening. Peptide screening is a research tool that pools active peptides primarily by immunoassay. Peptide screening can be used for protein interaction, functional analysis, epitope screening, especially in the field of agent research and development.